In this study, we aimed to examine the association of PD‐L1 with acquiring CSC phenotypes and chemoresistance, explore the mechanisms by which PD‐L1 expression is regulated, and identify biomarkers that predict the effectiveness of ICI‐based therapeutic regimens in CRC. This evidence concerns the gene CD274 and colorectal carcinoma.